Abstract
A search for susceptibility genes for psychiatric illness may benefit from recent advances in mouse molecular genetics. Molecular and phenotypic characterization of single gene mutations in mice with anomalies in neurophysiological or neurodevelopmental processes, disrupted in a psychiatric disease, can reveal new insights into the pathways that underlie these genetically complex illnesses. However, in the case of many psychiatric disorders such as autism and schizophrenia, the exact nature of these neurophysiological or neurodevelopmental processes is not known. For example, nothing is known about the molecular pathology underlying impaired social behavior, a prominent feature of both autism and schizophrenia. In this review we discuss published reports on genetic and pharmacological studies of social behavior in mice. We argue that paradigms for studies of the genetics and neurobiological origins of social interactions in mice are amenable to gene- and phenotype-based mutagenesis screens and that identification of a core set of genes that underlie social behavior in mice may provide important clues for our understanding of some aspects of autism and schizophrenia.
Keywords: endophenotype, psychiatric, neurodevelopmental, autism, schizophrenia
Current Genomics
Title: Social Behavior as an Endophenotype for Psychiatric Disorders Development of Mouse Models
Volume: 2 Issue: 1
Author(s): Dubravka Hranilovic and Maja Bucan
Affiliation:
Keywords: endophenotype, psychiatric, neurodevelopmental, autism, schizophrenia
Abstract: A search for susceptibility genes for psychiatric illness may benefit from recent advances in mouse molecular genetics. Molecular and phenotypic characterization of single gene mutations in mice with anomalies in neurophysiological or neurodevelopmental processes, disrupted in a psychiatric disease, can reveal new insights into the pathways that underlie these genetically complex illnesses. However, in the case of many psychiatric disorders such as autism and schizophrenia, the exact nature of these neurophysiological or neurodevelopmental processes is not known. For example, nothing is known about the molecular pathology underlying impaired social behavior, a prominent feature of both autism and schizophrenia. In this review we discuss published reports on genetic and pharmacological studies of social behavior in mice. We argue that paradigms for studies of the genetics and neurobiological origins of social interactions in mice are amenable to gene- and phenotype-based mutagenesis screens and that identification of a core set of genes that underlie social behavior in mice may provide important clues for our understanding of some aspects of autism and schizophrenia.
Export Options
About this article
Cite this article as:
Hranilovic Dubravka and Bucan Maja, Social Behavior as an Endophenotype for Psychiatric Disorders Development of Mouse Models, Current Genomics 2001; 2 (1) . https://dx.doi.org/10.2174/1389202013351138
DOI https://dx.doi.org/10.2174/1389202013351138 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Integrating Machine Learning with Genome Science: Pioneering Developments and Future Directions
Integrating machine learning (ML) with genome science is driving transformative advancements in fields such as genomics, personalized medicine, and drug discovery. Genomic data is vast and complex, making traditional analysis methods inadequate for uncovering deep insights. Machine learning, particularly deep learning models like convolutional neural networks (CNNs) and recurrent neural ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Psychiatric Disorders Associated with FXTAS
Current Psychiatry Reviews PDZ Domains at Excitatory Synapses: Potential Molecular Targets for Persistent Pain Treatment
Current Neuropharmacology Microarray Studies in Understanding the Mechanism of Action of Antiepileptic Drugs
Current Psychopharmacology Barbiturates: A Review of Synthesis and Antimicrobial Research Progress
Current Organic Synthesis Perspective on mTOR-dependent Protection in Status Epilepticus
Current Neuropharmacology Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies
Current Pharmaceutical Design N-Methylation of Nitrogen-Containing Organic Substrates: A Comprehensive Overview
Current Organic Chemistry Oxidative Damage Impact on Aging and Age-Related Diseases: Drug Targeting of Telomere Attrition and Dynamic Telomerase Activity Flirting with Imidazole-Containing Dipeptides
Recent Patents on Drug Delivery & Formulation Nanotechnology and Drug Delivery: Getting There is Only Half of the Challenge! (Commentary)
CNS & Neurological Disorders - Drug Targets Role of Noradrenergic and Orexinergic Neurons in General Anesthesia
Current Neuropharmacology Synthesis and Studies on Anticonvulsant and Antibacterial Activities of 1- Alkyl-4-(4H-1,2,4-triazol-4-yl)piperidine Derivatives
Letters in Drug Design & Discovery The Influence of Vaccine on Febrile Seizure
Current Neuropharmacology Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Substrates, Inhibitors and Activators of P-glycoprotein: Candidates for Radiolabeling and Imaging Perspectives
Current Topics in Medicinal Chemistry Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Current Medicinal Chemistry The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H<sub>3</sub> Receptor Antagonist in Patients with Mild to Moderate Alzheimer’s Disease: A Preliminary Investigation
Current Alzheimer Research Role of Wnt Signaling in the Control of Adult Hippocampal Functioning in Health and Disease: Therapeutic Implications
Current Neuropharmacology Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Ten Years of Progress in the Synthesis of 2-Pyridone Derivatives via Three / Four Component Reaction
Mini-Reviews in Organic Chemistry The Cold Case of Metabotropic Glutamate Receptor 6: Unjust Detention in the Retina?
Current Neuropharmacology